Business

10x Genomics guides higher Q4 & FY revenue than consensus (TXG:NASDAQ)

Avatar of Ui9Posted by


From 3rd to 4th quater symbol. Turned wooden cubes and changed words

Dzmitry Dzemidovich

  • 10x Genomics (NASDAQ:TXG) expects Q4 revenue of ~$165M, representing 9% growth Q/Q and a 10% decrease Y/Y; the figure remains above consensus estimates of $153.51M.
  • The highest Y/Y growth is estimated to come from the services segment, while the instruments


Rate this post

Leave a Reply

Email của bạn sẽ không được hiển thị công khai. Các trường bắt buộc được đánh dấu *